Supplemental Experimental Procedures
Recombinant DNAs, mutagenesis and yeast two-hybrid assays Y2H constructs encoding full-length human Ang2 and human Vps53 in pGBKT7 (Gal4 DNA-binding domain, BD) (Clontech, Mountain View, CA) were described before (Perez-Victoria et al., 2010) . Sequences encoding truncation mutants of Ang2 were amplified by PCR and cloned into pGBKT7. Sequences encoding the cytosolic domains of different SNAREs (Stx6, Stx8, Stx10, VAMP4) and fragments of these domains were PCR-amplified from human brain cDNA (Clontech) and cloned into pGADT7 (Gal4 activation domain, AD) (Clontech). pGEX-5X-1 (GE Healthcare, Piscataway, NJ) constructs encoding GST fused to the cytosolic domains of human Stx6 and Stx8, and mouse Vamp4 were described previously (Perez-Victoria and Bonifacino, 2009).
Sequences encoding the cytosolic domain of human Stx10 and truncation mutants of the cytosolic domain of human Stx6 were PCR-amplified and cloned in pGEX-5X-1.
Production of Ang2, Stx6 and Stx10 fragments for crystallography and ITC analysis
A human Ang2 construct encoding residues 1-69 was generated by PCR amplification and inserted into the pDB-HisGST vector using NdeI and BamHI restriction sites. Protein expression was carried out in E. coli BL21 (DE3) strain. Cells were grown in LB medium to OD 600 of 0.8 at which Ang2 expression was induced with 1 mM IPTG at 20°C overnight. Harvested cells were resuspended in lysis buffer containing 150 mM NaCl, 5 mM imidazole and 50 mM Tris-HCl pH 7.4 supplemented with 1 mg/ml lysozyme and 10 mM -mercaptoethanol (-ME). Lysis was carried out at 4°C by high-pressure homogenization at 27 Kpsi (Constant System, Ltd, UK). All subsequent steps were carried out 4°C. Insoluble material was removed by ultracentrifugation and supernatant loaded onto a gravity column packed with Ni-NTA Agarose resin (Qiagen, USA) and pre-equilibrated with lysis buffer. After extensive washing, the protein was eluted by addition of 250 mM imidazole to the buffer and then concentrated and loaded onto a HiLoad 16/60 Superdex 75 column (GE Healthcare) equilibrated with lysis buffer. Fractions containing His-GST-Ang2 identified by SDS-PAGE were collected and the His-GST tag was cleaved by incubation with tobacco etch virus (TEV) protease (Kapust and Waugh, 2000) . The sample was then concentrated and loaded onto a HiLoad 16/60 Superdex 75 column. Purified Ang2 was concentrated to 1 mg/ml, as measured by UV absorbance, and stored at -80°C.
Based on a previous structural analysis (Misura et al., 2002) , a construct comprising residues 3-110 of Stx6 was generated by PCR amplification and inserted into the His-parallel vector (Sheffield et al., 1999) between NcoI and EcoRI restriction sites.
Large-scale expression and cell lysis was carried out under the same conditions as for the Ang2 (1-69) construct. After elution from the Ni-NTA resin, the protein was incubated with TEV protease while dialyzed ON in 100 mM NaCl, 10 mM β-ME, 50 mM Tris-HCl pH 8.5. The sample was further purified by an ion exchange chromatography (HiTrap Q HP 5 ml column; GE Healthcare) using an isocratic gradient from 0.1 to 1 M NaCl in 20 column volumes. Fractions containing Stx6 identified by SDS-PAGE were concentrated and loaded onto a HiLoad 16/60 Superdex 75 column (GE Healthcare) preequilibrated in 150 mM NaCl, 10 mM β-ME, 50 mM Tris-HCl pH 7.4. Finally, fractions 8 containing Stx6 were concentrated to 2 mg/ml, as measured by UV absorbance, and stored at -80 °C. Stx10 (aa 1-110) was cloned and purified as described for Stx6.
Circular dichroism (CD)
CD data was recorded on a J-815 CD spectrometer (Jasco, UK) equipped with thermoelectric temperature control. Samples of Stx6, Stx10 and the mutant variants were diluted to 5-10 mM and placed in a 2-mm cell. All CD wavelength scans were performed at a constant temperature of 25ºC between 200 and 280 nm with a scanning speed of 50 nm∕ min and a data pitch of 1 nm. Data analysis was done using Origin and JASCO Spectra ManagerAE integrated software.
Antibodies
M2 antibody to the FLAG epitope was purchased form Sigma (St. Louis, MO).
Antibodies to clathrin heavy chain and Vti1a were from BD Biosciences (San Diego, CA).
Antibody to the V5 epitope was from Invitrogen. Rabbit antiserum to Stx6 was from Synaptic Systems (Göttingen, Germany). The generation of polyclonal antibody to Vps52 was described before (Perez-Victoria et al., 2008) . HRP-conjugated donkey antibodies to mouse and rabbit immunoglobulins were from GE Healthcare. 
